Research ArticleClinical Studies
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre
MIKLOS ACS, LASZLO HALMY, SABINA ISGANDAROVA, SEBASTIAN BLAJ, MICHAEL GERKEN, BERNHARD HORMANN and POMPILIU PISO
Anticancer Research February 2022, 42 (2) 1019-1029; DOI: https://doi.org/10.21873/anticanres.15563
MIKLOS ACS
1Department of General and Visceral Surgery, Hospital Barmherzige Brüder, Regensburg, Germany;
LASZLO HALMY
1Department of General and Visceral Surgery, Hospital Barmherzige Brüder, Regensburg, Germany;
SABINA ISGANDAROVA
1Department of General and Visceral Surgery, Hospital Barmherzige Brüder, Regensburg, Germany;
SEBASTIAN BLAJ
1Department of General and Visceral Surgery, Hospital Barmherzige Brüder, Regensburg, Germany;
MICHAEL GERKEN
2Tumor Center-Institute for Quality Management and Health Services Research, University of Regensburg, Regensburg, Germany;
BERNHARD HORMANN
3Department of Anaesthesiology and Intensive Care Medicine, Hospital Barmherzige Brüder, Regensburg, Germany
POMPILIU PISO
1Department of General and Visceral Surgery, Hospital Barmherzige Brüder, Regensburg, Germany;
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Anticancer Research
Vol. 42, Issue 2
February 2022
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre
MIKLOS ACS, LASZLO HALMY, SABINA ISGANDAROVA, SEBASTIAN BLAJ, MICHAEL GERKEN, BERNHARD HORMANN, POMPILIU PISO
Anticancer Research Feb 2022, 42 (2) 1019-1029; DOI: 10.21873/anticanres.15563
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre
MIKLOS ACS, LASZLO HALMY, SABINA ISGANDAROVA, SEBASTIAN BLAJ, MICHAEL GERKEN, BERNHARD HORMANN, POMPILIU PISO
Anticancer Research Feb 2022, 42 (2) 1019-1029; DOI: 10.21873/anticanres.15563
Jump to section
Related Articles
- No related articles found.